Evaluation of the Safety and Effectiveness of BOTOX® (Botulinum Toxin Type A) in the Treatment of Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity or Overactive Bladder: A Phase IV Non-interventional Post-marketing Surveillance Study in India

08/11/2016
31/03/2024
EU PAS number:
EUPAS16153
Study
Finalised
Documents
Study protocol
Initial protocol
English (388.22 KB - PDF) View document
Study results
Study results
English (42 KB - PDF) View document
Study report
Other information